AlphaStar Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $235K | Sell |
2,840
-87
| -3% | -$7.21K | 0.02% | 327 |
|
|
2025
Q1 | $237K | Sell |
2,927
-54
| -2% | -$4.38K | 0.02% | 166 |
|
|
2024
Q4 | $268K | Sell |
2,981
-206
| -6% | -$18.5K | 0.03% | 173 |
|
|
2024
Q3 | $315K | Buy |
+3,187
| New | +$315K | 0.03% | 302 |
|
|
2021
Q1 | – | Sell |
-9,258
| Closed | -$1.41M | – | 243 |
|
|
2020
Q4 | $1.41M | Sell |
9,258
-1,798
| -16% | -$273K | 0.24% | 82 |
|
|
2020
Q3 | $1.31M | Buy |
+11,056
| New | +$1.31M | 0.26% | 81 |
|